Evaluation of the clinical value of pharmacists' modifications of prescription errors

British Journal of Clinical Pharmacology

Volumn 58, Issue 5, 2004, Pages 503-511

  Buurma, Henk ^a,b   De Smet, Peter A G M ^c,d   Leufkens, Hubert G M ^b   Egberts, Antoine C G ^b,e  

^a SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Scientific Institute Dutch Pharmacists   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GGZ Midden Brabant   (Netherlands)

Author keywords

Community pharmacy services; Drug related problem; Evaluation studies; Intervention; Pharmaceutical care; Pharmacist; Prescription; Prescription error; Prescription modification

Indexed keywords

AMOXICILLIN; CISAPRIDE; DICLOFENAC; DOXYCYCLINE; ERYTHROMYCIN; ETHINYLESTRADIOL; FLUNITRAZEPAM; GLYCERYL TRINITRATE; HYDROCORTISONE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ITRACONAZOLE; NEOMYCIN; OFLOXACIN; SILDENAFIL; TETRACYCLINE; TRAMADOL;

ARTICLE; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; GENERAL PRACTICE; HUMAN; MEDICATION ERROR; PHARMACIST; POLYPHARMACY; PRESCRIPTION; PRESCRIPTION MODIFICATION; PRIORITY JOURNAL;

CLINICAL COMPETENCE; COMMUNITY PHARMACY SERVICES; HUMANS; MEDICATION ERRORS; NETHERLANDS; PHARMACISTS; PRESCRIPTIONS, DRUG; PROFESSIONAL PRACTICE;

EID: 9144234127     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02181.x     Document Type: Article

References (20)

1. Weingart SN, Wilson RMcL, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ 2000; 320: 774-7.
2. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care 2000; 12: 69-76.
3. Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human. Building a Safer Health System. Washington DC: National Academy Press, 1999.
4. Westerlund LOT, Marklund BR, Handl WHA, Thunberg ME, Allebeck P. Non-prescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001; 35: 1343-9.
5. Boyko WL, Yurkowski PJ, Ivey MF, Armistead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health-Syst Pharm 1997; 54: 1591-5.
6. Bouvy ML, Buurma H, Egberts TC. Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention. J Clin Pharm Ther 2002; 27: 107-10.
7. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2000; 3: CD000336.
8. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999; 33: 1336-55.
9. Tully MP, Seston EM. Impact of pharmacists providing a prescription review and monitoring in ambulatory care or community practice. Ann Pharmacother 2000; 34: 1320-31.
10. Buurma H, De Smet PAGM, van den Hoff OP, Egberts ACG. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001; 52: 85-91.
11. Wright DJ, Aykroyd RG, Chrystyn H. Rating clinical pharmacy interventions by clinical panels: which health professionals should be included? Br J Clin Pharmacol 1998; 46: 278P.
12. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999; 47: 695-700.
13. Rupp MT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 1992; 26: 1580-4.
14. Caleo S, Benrimoj SI, Collins D, Lauchlan R, Stewart K. Clinical evaluation of community pharmacists' interventions, Int J Pharm Pract 1996; 4: 221-7.
15. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652-8.
16. Hansten PD, Horn JR. Drug Interactions Analysis and Management. St. Louis, Missouri: Facts and comparisons, 2002.
17. Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M. Metabolic Drug Interactions. Philadelphia: Lippincott Williams & Wilkins, 2000.
18. Stockley IH. Drug Interactions, 6th edn. London: The Pharmaceutical Press, 2002.
19. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378-82.
20. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1995.